GAS5 functions as a competing endogenous RNA to repress miR-21, which regulates its downstream target SOX5, resulting in the sensitivity of renal cell carcinoma to sorafenib. This evidence concerns the gene SOX5 and hereditary clear cell renal cell carcinoma.